Jennifer Miller: Scoring the Ethics of Pharma Companies

Howie and Harlan discuss Harlan's large new study tracking the trajectory of patient safety in hospitals, and consider how individuals should respond to the latest COVID-19 variants. They're joined by Jennifer Miller, a Yale bioethicist and the director of the Good Pharma Scorecard, which evaluates the performance of pharmaceutical companies on measures like the transparency of clinical trials and the accessibility of medicines. 

Links:

“New Federal Study Evaluates the Safety of US Hospitals and the Answer Is…”

“Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019”

Good Pharma Scorecard

Learn more about the MBA for Executives program at Yale SOM.

Email Howie and Harlan comments or questions.